Companion Diagnostic Development Services
Haematological Malignancies (e.g., Acute Leukaemia)
Development/CommercialActive
Key Facts
Indication
Haematological Malignancies (e.g., Acute Leukaemia)
Phase
Development/Commercial
Status
Active
Company
About Oxford Gene Technology
Oxford Gene Technology (OGT) is a leading global diagnostic genomics company founded in 1995, offering a portfolio of FISH, NGS, and array products for clinical and research use in oncology and rare diseases. The company operates on a partnership model, providing assay development and companion diagnostic services, particularly for haematological malignancies. With products used in over 85 countries and a strong emphasis on customer collaboration, OGT is positioned as a key enabler of precision medicine, leveraging its deep experience in molecular genetics to deliver reliable genomic insights.
View full company profile